Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
Adam S Fleisher
Affiliation
Banner Alzheimer's Institute, University of California
ORCID
Career Start Year
2001
Papers
120
H Index
57
Expertise
CM4AI Collaborator
PMID
Paper Title
Journal Title
Published Year
36855201
Early tau detection in flortaucipir images: validation in autopsy-confirmed data and implications for disease progression.
Alzheimers Res Ther
2023
35099509
Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical Spectrum.
JAMA Neurol
2022
35191506
Hemispheric Asymmetry and Atypical Lobar Progression of Alzheimer-Type Tauopathy.
J Neuropathol Exp Neurol
2022
34585215
Donanemab (LY3002813) Phase 1b Study in Alzheimer's Disease: Rapid and Sustained Reduction of Brain Amyloid Measured by Florbetapir F18 Imaging.
J Prev Alzheimers Dis
2021
33682705
Relationships Between Cognition and Neuropathological Tau in Alzheimer's Disease Assessed by 18F Flortaucipir PET.
J Alzheimers Dis
2021
33614894
Lanabecestat: Neuroimaging results in early symptomatic Alzheimer's disease.
Alzheimers Dement (N Y)
2021
32338734
Positron Emission Tomography Imaging With [18F]flortaucipir and Postmortem Assessment of Alzheimer Disease Neuropathologic Changes.
JAMA Neurol
2020
29188296
Association of Cerebral Amyloid-β Aggregation With Cognitive Functioning in Persons Without Dementia.
JAMA Psychiatry
2018
29799984
Use of Flutemetamol F 18-Labeled Positron Emission Tomography and Other Biomarkers to Assess Risk of Clinical Progression in Patients With Amnestic Mild Cognitive Impairment.
JAMA Neurol
2018
29955651
A simulation study comparing slope model with mixed-model repeated measure to assess cognitive data in clinical trials of Alzheimer's disease.
Alzheimers Dement (N Y)
2018
30326851
Retrospective assessment of patient characteristics and healthcare costs prior to a diagnosis of Alzheimer's disease in an administrative claims database.
BMC Geriatr
2018
29780867
Topographic staging of tau positron emission tomography images.
Alzheimers Dement (Amst)
2018
29601787
Prevalence of the apolipoprotein E ε4 allele in amyloid β positive subjects across the spectrum of Alzheimer's disease.
Alzheimers Dement
2018
28795133
Performance of [<sup>18</sup>F]flutemetamol amyloid imaging against the neuritic plaque component of CERAD and the current (2012) NIA-AA recommendations for the neuropathologic diagnosis of Alzheimer's disease.
Alzheimers Dement (Amst)
2017
28365320
Use of white matter reference regions for detection of change in florbetapir positron emission tomography from completed phase 3 solanezumab trials.
Alzheimers Dement
2017
28410658
The Role of Neuroimaging in the Assessment of the Cognitively Impaired Elderly.
Neurol Clin
2017
27733827
A Triple Network Connectivity Study of Large-Scale Brain Systems in Cognitively Normal APOE4 Carriers.
Front Aging Neurosci
2016
28229124
Functional limitations and health care resource utilization for individuals with cognitive impairment without dementia: Findings from a United States population-based survey.
Alzheimers Dement (Amst)
2016
25580592
Associations between biomarkers and age in the presenilin 1 E280A autosomal dominant Alzheimer disease kindred: a cross-sectional study.
JAMA Neurol
2015
27239516
Clinical use of amyloid-positron emission tomography neuroimaging: Practical and bioethical considerations.
Alzheimers Dement (Amst)
2015
26156687
Striatal and Pallidal Activation during Reward Modulated Movement Using a Translational Paradigm.
J Int Neuropsychol Soc
2015
26121081
Brain Imaging and Blood Biomarker Abnormalities in Children With Autosomal Dominant Alzheimer Disease: A Cross-Sectional Study.
JAMA Neurol
2015
25849033
Florbetapir PET, FDG PET, and MRI in Down syndrome individuals with and without Alzheimer's dementia.
Alzheimers Dement
2015
25873426
Aberrant white matter networks mediate cognitive impairment in patients with silent lacunar infarcts in basal ganglia territory.
J Cereb Blood Flow Metab
2015
25988462
Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis.
JAMA
2015
25988463
Prevalence of amyloid PET positivity in dementia syndromes: a meta-analysis.
JAMA
2015
25622185
Phase 3 trial of flutemetamol labeled with radioactive fluorine 18 imaging and neuritic plaque density.
JAMA Neurol
2015
25745091
Improved power for characterizing longitudinal amyloid-β PET changes and evaluating amyloid-modifying treatments with a cerebral white matter reference region.
J Nucl Med
2015
23562429
Subjective cognitive decline: self and informant comparisons.
Alzheimers Dement
2014
25070071
The value of biomarker comparisons between autosomal dominant and late-onset Alzheimer disease.
JAMA Neurol
2014
24751827
An empirically derived composite cognitive test score with improved power to track and evaluate treatments for preclinical Alzheimer's disease.
Alzheimers Dement
2014
24747536
In vivo performance of a microfabricated catheter for intraparenchymal delivery.
J Neurosci Methods
2014
24816373
The Alzheimer's prevention initiative composite cognitive test score: sample size estimates for the evaluation of preclinical Alzheimer's disease treatments in presenilin 1 E280A mutation carriers.
J Clin Psychiatry
2014
24946874
Aberrant functional networks connectivity and structural atrophy in silent lacunar infarcts: relationship with cognitive impairments.
J Alzheimers Dis
2014
24940515
Out of sight, out of mind: the case of a 62-year-old man with visual complaints and cognitive decline.
Prim Care Companion CNS Disord
2014
24614494
Florbetapir F 18 amyloid PET and 36-month cognitive decline: a prospective multicenter study.
Mol Psychiatry
2014
24614201
Structural and functional brain changes in the default mode network in subtypes of amnestic mild cognitive impairment.
J Geriatr Psychiatry Neurol
2014
24335535
Neuropathologic heterogeneity does not impair florbetapir-positron emission tomography postmortem correlates.
J Neuropathol Exp Neurol
2014
24276092
Brain differences in infants at differential genetic risk for late-onset Alzheimer disease: a cross-sectional imaging study.
JAMA Neurol
2014
24411134
A phase1 study of stereotactic gene delivery of AAV2-NGF for Alzheimer's disease.
Alzheimers Dement
2014
24164929
Neuropsychiatric symptoms and regional neocortical atrophy in mild cognitive impairment and Alzheimer's disease.
Am J Alzheimers Dis Other Demen
2014
23583233
Fibrillar amyloid correlates of preclinical cognitive decline.
Alzheimers Dement
2014
23541188
The neuropsychology of normal aging and preclinical Alzheimer's disease.
Alzheimers Dement
2014
22665720
A sparse structure learning algorithm for Gaussian Bayesian Network identification from high-dimensional data.
IEEE Trans Pattern Anal Mach Intell
2013
24511437
Hypersexuality in dementia: a case presentation with discussion.
Prim Care Companion CNS Disord
2013
24252435
Clinical and multimodal biomarker correlates of ADNI neuropathological findings.
Acta Neuropathol Commun
2013
24171149
A rapid turn of events: sudden physical and cognitive decline.
Prim Care Companion CNS Disord
2013
23840615
Association between an Alzheimer's Disease-Related Index and APOE ε4 Gene Dose.
PLoS One
2013
23836404
Genetic susceptibility for Alzheimer disease neuritic plaque pathology.
JAMA Neurol
2013
23930237
As time goes by.
Prim Care Companion CNS Disord
2013
1 - 50 of 120
Column Actions
Search
Recommended Authors
Federico d'Oleire Uquillas
Princeton Neuroscience Institute, Princeton University
Career Start Year
2015
Number of shared co-authors
8
Heidi I L Jacobs
Maastricht University
Career Start Year
2011
Number of shared co-authors
11
Hyun-Sik Yang
Massachusetts General Hospital, the Gordon Center for Medical Imaging
Career Start Year
2011
Number of shared co-authors
27
Michael Sch??ll
University of Gothenburg
Career Start Year
2011
Number of shared co-authors
12
Caitlin S Latimer
University of Washington
Career Start Year
2011
Number of shared co-authors
5
Jimit Doshi
University of Pennsylvania
Career Start Year
2011
Number of shared co-authors
13
Michel J Grothe
Instituto de Salud Carlos III
Career Start Year
2010
Number of shared co-authors
22
Bernard Hanseeuw
Gordon Center for Medical Imaging, Massachusetts General Hospital
Career Start Year
2010
Number of shared co-authors
19
Ozioma C Okonkwo
University of Wisconsin-Madison
Career Start Year
2006
Number of shared co-authors
31
Deniz Erten-Lyons
Oregon Health and Science University
Career Start Year
2006
Number of shared co-authors
11
Jonathan Graff-Radford
Mayo Clinic Rochester
Career Start Year
2006
Number of shared co-authors
27
Richard S Isaacson
Weill Cornell Medical College
Career Start Year
2005
Number of shared co-authors
11
Ilya M Nasrallah
Perelman School of Medicine, University of Pennsylvania
Career Start Year
1998
Number of shared co-authors
20
AmanPreet Badhwar
University of Montreal
Career Start Year
1998
Number of shared co-authors
2
Eric McDade
Washington University St. Louis
Career Start Year
1998
Number of shared co-authors
51
Lisa C Silbert
Oregon Center for Aging and Technology (ORCATECH), Oregon Health & Science University
Career Start Year
1996
Number of shared co-authors
26
Catherine E Munro
Brigham and Women's Hospital Boston Massachusetts USA.
Career Start Year
1995
Number of shared co-authors
3
Andrew Simmons
Institute of Psychiatry, King's College London
Career Start Year
1994
Number of shared co-authors
35
David S Geldmacher
University of Alabama at Birmingham
Career Start Year
1993
Number of shared co-authors
18
Steven D Edland
University of California San Diego
Career Start Year
1993
Number of shared co-authors
38
Adam L Boxer
UCSF Weill Institute for Neurosciences, University of California san francisco
Career Start Year
1992
Number of shared co-authors
92
Rhoda Au
Boston University Chobanian & Avedisian School of Medicine
Career Start Year
1992
Number of shared co-authors
40
Kwangsik Nho
Indiana University School of Medicine
Career Start Year
1992
Number of shared co-authors
47
Bradley F Boeve
Mayo Clinic Rochester
Career Start Year
1991
Number of shared co-authors
95
Timothy G Lesnick
Mayo Clinic
Career Start Year
1988
Number of shared co-authors
20
Paul E Schulz
The University of Texas Health Science Center at Houston, McGovern Medical School
Career Start Year
1988
Number of shared co-authors
6
Simon Lovestone
Janssen Medical Ltd
Career Start Year
1986
Number of shared co-authors
76
Joel H Kramer
UCSF Weill Institute for Neurosciences, University of California san francisco
Career Start Year
1985
Number of shared co-authors
94
James B Leverenz
Lou Ruvo Center for Brain Health, Cleveland Clinic
Career Start Year
1980
Number of shared co-authors
75
Joseph J Locascio
Harvard Medical School, Massachusetts General Hospital
Career Start Year
1975
Number of shared co-authors
11
row(s) 1 - 30 of 30
Collaborators
Kewei Chen
Beijing Normal University
Co-authored papers
50
Eric M Reiman
Banner Alzheimer's Institute
Co-authored papers
48
Pierre N Tariot
Banner Alzheimer's Institute
Co-authored papers
28
Mark A Mintun
Mallinckrodt Institute of Radiology , Washington University School of Medicine
Co-authored papers
20
Daniel Bandy
Banner Alzheimer's Institute
Co-authored papers
15
Gene E Alexander
Evelyn F. McKnight Brain Institute, University of Arizona
Co-authored papers
15
Michael W Weiner
University of California San Francisco
Co-authored papers
14
Marwan N Sabbagh
Barrow Neurological Institute
Co-authored papers
13
William J Jagust
Helen Wills Neuroscience Institute, University of California Berkeley
Co-authored papers
12
Carl H Sadowsky
Premier Research Institute and NOVA SE University
Co-authored papers
12
Pudugramam Murali Doraiswamy
Duke University School of Medicine
Co-authored papers
10
Clifford R Jack
Mayo Clinic Rochester
Co-authored papers
10
Paul M Thompson
University of Southern California
Co-authored papers
9
Reisa A Sperling
Brigham and Women's Hospital, Massachusetts General Hospital
Co-authored papers
9
Paul S Aisen
Alzheimer's Therapeutic Research Institute, University of Southern California
Co-authored papers
9
Danielle Harvey
University of California davis
Co-authored papers
8
Keith A Johnson
Brigham and Women's Hospital, Massachusetts General Hospital, Harvard Medical School
Co-authored papers
7
Michael D Devous
University of Texas Southwestern Medical Center
Co-authored papers
7
Matthew J Huentelman
The Translational Genomics Research Institute (TGen)
Co-authored papers
7
Mony J de Leon
Brain Health Imaging Institute
Co-authored papers
7
David A Wolk
University of Pennsylvania
Co-authored papers
7
John C Morris
Washington University School of Medicine
Co-authored papers
6
Ralph E Coleman
Duke University School of Medicine
Co-authored papers
6
Anders M Dale
University of California San Diego
Co-authored papers
6
Robert A Koeppe
University of Michigan ann arbor
Co-authored papers
6
Norman L Foster
University of Utah
Co-authored papers
6
Norbert Schuff
University of California san francisco
Co-authored papers
6
Stephen Salloway
Butler Hospital, and Warren Alpert Medical School of Brown University
Co-authored papers
5
Ronald C Petersen
Mayo Clinic Rochester
Co-authored papers
5
Matt A Bernstein
Mayo Clinic
Co-authored papers
5
1 - 30